MARCUS JOEL S (CIK 1216955) reported 11 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2026-05-07). Recent activity: Buy ARE (3,989 shares), Buy ARE (3,511 shares), Buy ARE (17,300 shares), Buy ARE (7,700 shares), Sell ARE (14,671 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-05-07 | ALEXANDRIA REAL ESTATE EQUITIES, INC. (ARE) | Executive Chairman | Buy | 3,989 | $183,454 |
| 2026-05-07 | ALEXANDRIA REAL ESTATE EQUITIES, INC. (ARE) | Executive Chairman | Buy | 3,511 | $164,104 |
| 2026-02-13 | ALEXANDRIA REAL ESTATE EQUITIES, INC. (ARE) | Executive Chairman | Buy | 17,300 | $929,702 |
| 2026-02-13 | ALEXANDRIA REAL ESTATE EQUITIES, INC. (ARE) | Executive Chairman | Buy | 7,700 | $418,187 |
| 2026-01-26 | ALEXANDRIA REAL ESTATE EQUITIES, INC. (ARE) | Executive Chairman | Sell | 14,671 | $0 |
| 2026-01-26 | ALEXANDRIA REAL ESTATE EQUITIES, INC. (ARE) | Executive Chairman | Sell | 35,075 | $0 |
| 2026-01-13 | ALEXANDRIA REAL ESTATE EQUITIES, INC. (ARE) | Executive Chairman | Buy | 100,056 | $0 |
| 2026-01-05 | ALEXANDRIA REAL ESTATE EQUITIES, INC. (ARE) | Executive Chairman | Buy | 31,270 | $0 |
| 2025-04-02 | Intra-Cellular Therapies, Inc. (ITCI) | Director | Sell | 48,238 | $6.4M |
| 2025-04-02 | Intra-Cellular Therapies, Inc. (ITCI) | Director | Sell | 10,000 | $1.3M |
| 2025-02-26 | Intra-Cellular Therapies, Inc. (ITCI) | Director | Buy | 7,009 | $447,104 |
Source: SEC Form 4 filings · as of 2026-05-07